Horizon Pharma (Nasdaq: HZNP) forecast first and second quarter revenue that fell far short of analyst expectations sending the stock price plummeting $4.69 to $13.53.
Horizon Pharma's forecast falls short
April 12, 2016 at 14:23 PM EDT
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.